Status:
COMPLETED
Study of Retinal Function Using Electroretinogram in Regular Alcohol Users
Lead Sponsor:
Centre Psychothérapique de Nancy
Conditions:
Alcohol Use Disorder
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Alcohol is a major public health problem and its neurotoxic effects are, among other things, responsible for altering the functioning of cerebral neurotransmission pathways. The retina is an anatomic...
Eligibility Criteria
Inclusion
- For alcohol consumer with alcohol use disorder :
- aged between 18 and 35 years
- alcohol use disorder according to the DSM 5
- affiliation to a social security scheme
Exclusion
- psychoactive substance consumption (other than alcohol)
- psychiatric disease in progress according to the DSM 5
- neurologic disease in progress
- mental impairment making it difficult or impossible to participate to the study
- major under guardianship or curatorship or under safeguarding of justice
- pregnant women or feeding
- people in emergency situation
- participation to another interventional study
- retinal disease in progress
- chronic glaucoma
- ophtalmic disease affecting the visual acuity
- ocular infection in progress
- urinary positive drug check the day of the inclusion
- postive Breathalyser the day of the inclusion
Key Trial Info
Start Date :
May 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03818971
Start Date
May 13 2019
End Date
March 22 2021
Last Update
December 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Psychothérapique de Nancy
Laxou, Nancy, France, 54520